356856554	356856554	CD	B-NP	O
|	|	NNP	I-NP	O
JH	JH	NNP	I-NP	O
|	|	VBD	B-VP	O
40271494	40271494	CD	B-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
7185197	7185197	CD	B-NP	O
|	|	CC	I-NP	O
10/16/2003	10/16/2003	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
RENAL	RENAL	NNP	I-NP	I-protein
FAILURE	FAILURE	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Signed	Signed	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/16/2003	10/16/2003	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
8/17/2003	8/17/2003	CD	B-NP	O
ATTENDING	ATTENDING	NN	I-NP	O
:	:	:	O	O
DALE	DALE	NNP	B-NP	O
NED	NED	NNP	I-NP	O
SAVITCH	SAVITCH	NNP	I-NP	O
MD	MD	NNP	I-NP	O
ATTENDING	ATTENDING	NNP	I-NP	O
PHYSICIAN	PHYSICIAN	NNP	I-NP	O
ON	ON	NNP	I-NP	O
ADMISSION	ADMISSION	NNP	I-NP	O
:	:	:	O	O
Emmitt	Emmitt	NNP	B-NP	O
Marc	Marc	NNP	I-NP	O
Guier	Guier	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
ATTENDING	ATTENDING	NNP	I-NP	O
PHYSICIAN	PHYSICIAN	NNP	I-NP	O
ON	ON	NNP	I-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
:	:	:	O	O
Marco	Marco	NNP	B-NP	O
Mccaster	Mccaster	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CHIEF	CHIEF	NNP	I-NP	O
COMPLAINT	COMPLAINT	NNP	I-NP	O
:	:	:	O	O
Mr.	Mr.	NNP	B-NP	O
Gramby	Gramby	NNP	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
43-year-old	43-year-old	JJ	I-NP	O
man	man	NN	I-NP	O
with	with	IN	B-PP	O
morbid	morbid	NN	B-NP	O
obesity	obesity	NN	I-NP	O
,	,	,	O	O
type	type	NN	B-NP	O
II	II	CD	I-NP	O
diabetes	diabete	NNS	I-NP	O
,	,	,	O	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
hyperlipidemia	hyperlipidemia	NN	B-NP	O
,	,	,	O	O
chronic	chronic	JJ	B-NP	O
renal	renal	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
severe	severe	JJ	B-NP	O
peripheral	peripheral	JJ	I-NP	O
arterial	arterial	JJ	I-NP	O
disease	disease	NN	I-NP	O
status	status	NN	I-NP	O
post	post	IN	B-PP	O
femoral	femoral	JJ	B-NP	O
popliteal	popliteal	JJ	I-NP	O
bypass	bypass	NN	I-NP	O
in	in	IN	B-PP	O
September	September	NNP	B-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
complicated	complicate	VBN	I-VP	O
by	by	IN	B-PP	O
repeated	repeat	VBN	B-NP	O
return	return	NN	I-NP	O
of	of	IN	B-PP	O
cellulitis	cellulitis	NN	B-NP	B-protein
x	x	SYM	B-NP	I-protein
2	2	CD	I-NP	I-protein
who	who	WP	B-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
with	with	IN	B-PP	O
cellulitis	cellulitis	NN	B-NP	O
and	and	CC	I-NP	O
volume	volume	NN	I-NP	O
overload	overload	NN	I-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
had	have	VBD	I-VP	O
two	two	CD	B-NP	O
wound	wound	JJ	I-NP	O
complications	complication	NNS	I-NP	O
after	after	IN	B-PP	O
his	his	PRP$	B-NP	O
femoral	femoral	JJ	I-NP	O
popliteal	popliteal	JJ	I-NP	O
bypass	bypass	NN	I-NP	O
requiring	require	VBG	B-VP	O
two	two	CD	B-NP	O
separate	separate	JJ	I-NP	O
incisions	incision	NNS	I-NP	O
and	and	CC	I-NP	O
drainages	drainage	NNS	I-NP	O
including	include	VBG	B-PP	O
courses	course	NNS	B-NP	O
of	of	IN	B-PP	O
intravenous	intravenous	JJ	B-NP	O
nafcillin	nafcillin	NN	I-NP	O
x	x	SYM	B-NP	O
4	4	CD	B-NP	O
weeks	week	NNS	I-NP	O
and	and	CC	B-PP	O
with	with	IN	B-PP	O
vancomycin	vancomycin	NN	B-NP	B-protein
x	x	SYM	O	I-protein
4	4	CD	B-NP	I-protein
weeks	week	NNS	I-NP	I-protein
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
seen	see	VBN	I-VP	O
by	by	IN	B-PP	O
Vascular	Vascular	NNP	B-NP	O
Surgery	Surgery	NNP	I-NP	O
five	five	CD	B-NP	O
days	day	NNS	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
and	and	CC	O	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
dicloxacillin	dicloxacillin	NN	B-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
third	third	JJ	I-NP	O
episode	episode	NN	I-NP	O
of	of	IN	B-PP	O
cellulitis	cellulitis	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
also	also	RB	I-VP	O
presented	present	VBN	I-VP	O
with	with	IN	B-PP	O
fluid	fluid	NN	B-NP	O
overload	overload	NN	I-NP	O
and	and	CC	I-NP	O
spironolactone	spironolactone	NN	I-NP	O
was	be	VBD	B-VP	O
added	add	VBN	I-VP	O
to	to	TO	B-PP	O
his	his	PRP$	B-NP	O
diuretic	diuretic	JJ	I-NP	O
regimen	regimen	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
care	care	NN	I-NP	O
provider	provider	NN	I-NP	O
saw	see	VBD	B-VP	O
him	him	PRP	B-NP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
reported	report	VBD	B-VP	O
a	a	DT	B-NP	O
recent	recent	JJ	I-NP	O
fall	fall	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
primary	primary	JJ	I-NP	O
care	care	NN	I-NP	O
physician	physician	NN	I-NP	O
recommended	recommend	VBD	B-VP	O
admission	admission	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
hospital	hospital	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
does	do	VBZ	B-VP	O
report	report	VB	I-VP	O
some	some	DT	B-NP	O
fever	fever	NN	I-NP	O
and	and	CC	O	O
shaking	shake	VBG	B-VP	O
chills	chill	NNS	B-NP	O
and	and	CC	O	O
decreased	decrease	VBN	B-NP	O
appetite	appetite	NN	I-NP	O
.	.	.	O	O

Also	Also	RB	B-ADVP	O
,	,	,	O	O
reported	report	VBD	B-VP	O
weakness	weakness	NN	B-NP	O
in	in	IN	B-PP	O
bilateral	bilateral	JJ	B-NP	O
lower	low	JJR	I-NP	O
extremities	extremity	NNS	I-NP	O
and	and	CC	O	O
right	right	JJ	B-NP	O
foot	foot	NN	I-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
chronic	chronic	JJ	B-NP	O
loss	loss	NN	I-NP	O
of	of	IN	B-PP	O
sensation	sensation	NN	B-NP	O
in	in	IN	B-PP	O
both	both	DT	B-NP	O
feet	foot	NNS	I-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
Morbid	Morbid	NNP	B-NP	O
obesity	obesity	NN	I-NP	O
,	,	,	O	O
type	type	NN	B-NP	O
II	II	CD	I-NP	O
diabetes	diabete	NNS	I-NP	O
,	,	,	O	O
chronic	chronic	JJ	B-NP	O
renal	renal	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
baseline	baseline	NN	I-NP	O
creatinine	creatinine	NN	I-NP	O
of	of	IN	B-PP	O
2-2	2-2	JJ	B-NP	B-protein
.5	.5	NN	I-NP	I-protein
,	,	,	O	O
dyslipidemia	dyslipidemia	NN	B-NP	O
,	,	,	O	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
peripheral	peripheral	JJ	B-NP	O
vascular	vascular	JJ	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
anemia	anemia	NN	B-NP	O
,	,	,	O	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
deep	deep	JJ	B-NP	O
vein	vein	NN	I-NP	O
thrombosis	thrombosis	NN	I-NP	O
,	,	,	O	O
obstructive	obstructive	JJ	B-NP	O
sleep	sleep	NN	I-NP	O
apnea	apnea	NN	I-NP	O
,	,	,	O	O
anger	anger	NN	B-NP	O
disorder	disorder	NN	I-NP	O
,	,	,	O	O
peptic	peptic	JJ	B-NP	O
ulcer	ulcer	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
tinea	tinea	NN	B-NP	O
pedis	pedis	NN	I-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
ON	ON	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
Atenolol	Atenolol	NN	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
spironolactone	spironolactone	NN	B-NP	O
,	,	,	O	O
torsemide	torsemide	NN	B-NP	O
160	160	CD	I-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
,	,	,	O	O
Hyzaar	Hyzaar	NNP	B-NP	O
50/12	50/12	CD	I-NP	O
.5	.5	CD	I-NP	O
q.	q.	NN	I-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
lisinopril	lisinopril	NN	B-NP	O
60	60	CD	I-NP	O
mg	mg	NN	I-NP	O
q.	q.	NN	I-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
Neurontin	Neurontin	NN	B-NP	O
1200	1200	CD	I-NP	O
mg	mg	NN	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
,	,	,	O	O
Norvasc	Norvasc	NNP	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
q.a.m.	q.a.m.	NN	I-NP	O
and	and	CC	O	O
5	5	CD	B-NP	O
mg	mg	NN	I-NP	O
q.p.m.	q.p.m.	NN	I-NP	O
,	,	,	O	O
Coumadin	Coumadin	NN	B-NP	O
8	8	CD	I-NP	O
mg	mg	NN	I-NP	O
,	,	,	O	O
aspirin	aspirin	NN	B-NP	O
,	,	,	O	O
Humalog	Humalog	NNP	B-NP	O
sliding	slide	VBG	I-NP	O
scale	scale	NN	I-NP	O
,	,	,	O	O
Percocet	Percocet	NNP	B-NP	O
,	,	,	O	O
Pletal	Pletal	NNP	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
,	,	,	O	O
Procrit	Procrit	NN	B-NP	O
,	,	,	O	O
Zantac	Zantac	NN	B-NP	O
,	,	,	O	O
nitroglycerin	nitroglycerin	NN	B-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
NPH	NPH	NN	B-NP	O
80	80	CD	I-NP	O
q.a.m.	q.a.m.	NN	I-NP	O
and	and	CC	I-NP	O
q.p.m.	q.p.m.	NN	I-NP	O
PHYSICAL	PHYSICAL	NN	I-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
:	:	:	O	O
On	On	IN	B-PP	O
physical	physical	JJ	B-NP	O
exam	exam	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
afebrile	afebrile	JJ	B-ADJP	O
and	and	CC	O	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
temperature	temperature	NN	I-NP	O
of	of	IN	B-PP	O
99	99	CD	B-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
heart	heart	NN	I-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
70	70	CD	B-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
200/79	200/79	CD	I-NP	O
possibly	possibly	RB	B-VP	O
taken	take	VBN	I-VP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
undersized	undersized	JJ	I-NP	O
cuff	cuff	NN	I-NP	O
,	,	,	O	O
18	18	CD	B-NP	O
and	and	CC	I-NP	O
99	99	CD	I-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
is	be	VBZ	B-VP	O
obese	obese	JJ	B-NP	O
and	and	CC	I-NP	O
comfortable	comfortable	JJ	I-NP	O
man	man	NN	I-NP	O
in	in	IN	B-PP	O
bed	bed	NN	B-NP	O
and	and	CC	B-PP	O
in	in	IN	B-PP	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	O
distress	distress	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
JVP	JVP	NN	I-NP	B-protein
could	could	MD	B-VP	O
not	not	RB	I-VP	O
be	be	VB	I-VP	O
assessed	assess	VBN	I-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
size	size	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
neck	neck	NN	I-NP	O
.	.	.	O	O

Heart	Heart	NN	B-NP	O
sounds	sound	NNS	I-NP	O
were	be	VBD	B-VP	O
distant	distant	JJ	B-ADJP	O
.	.	.	O	O

Chest	Chest	NNP	B-NP	O
was	be	VBD	B-VP	O
clear	clear	JJ	B-ADJP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
abdomen	abdomen	NN	I-NP	O
is	be	VBZ	B-VP	O
obese	obese	JJ	B-ADJP	O
with	with	IN	B-PP	O
bowel	bowel	NN	B-NP	O
sounds	sound	NNS	I-NP	O
,	,	,	O	O
nontender	nontender	JJ	B-ADJP	O
,	,	,	O	O
and	and	CC	O	O
nondistended	nondistended	JJ	B-ADJP	O
.	.	.	O	O

Extremities	Extremity	NNS	B-NP	O
:	:	:	O	O
Notable	Notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
3	3	CD	B-NP	O
+	+	SYM	I-NP	O
edema	edema	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
including	include	VBG	B-PP	O
1	1	CD	B-NP	O
+	+	SYM	B-NP	O
extending	extend	VBG	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
groin	groin	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
pulses	pulse	NNS	I-NP	O
were	be	VBD	B-VP	O
Dopplerable	Dopplerable	JJ	B-ADJP	O
bilaterally	bilaterally	RB	B-ADVP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
triphasic	triphasic	JJ	I-NP	O
wave	wave	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
and	and	CC	I-NP	O
biphasic	biphasic	JJ	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
left	left	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
medial	medial	JJ	I-NP	O
aspect	aspect	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
right	right	JJ	I-NP	O
leg	leg	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
surgical	surgical	JJ	I-NP	O
scar	scar	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
healed	healed	JJ	I-NP	O
annular	annular	JJ	I-NP	O
burn	burn	NN	I-NP	O
wound	wound	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
medial	medial	JJ	I-NP	O
knee	knee	NN	I-NP	O
and	and	CC	O	O
an	an	DT	B-NP	O
area	area	NN	I-NP	O
of	of	IN	B-PP	O
erythema	erythema	NN	B-NP	O
along	along	IN	B-PP	O
the	the	DT	B-NP	O
scar	scar	NN	I-NP	O
with	with	IN	B-PP	O
warmth	warmth	NN	B-NP	O
,	,	,	O	O
moderate	moderate	JJ	B-NP	O
tenderness	tenderness	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
fluctuance	fluctuance	NN	I-NP	O
and	and	CC	O	O
minimal	minimal	JJ	B-NP	O
induration	induration	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
discharge	discharge	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
diameter	diameter	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
right	right	JJ	I-NP	O
leg	leg	NN	I-NP	O
was	be	VBD	B-VP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
his	his	PRP$	B-NP	O
left	left	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
right	right	JJ	I-NP	O
heel	heel	NN	I-NP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
intact	intact	JJ	I-NP	O
?	?	.	O	O
?	?	.	O	O
blough	blough	JJ	B-ADJP	O
?	?	.	O	O
?	?	.	O	O
and	and	CC	O	O
his	his	PRP$	B-NP	O
left	left	JJ	I-NP	O
heel	heel	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
dry	dry	JJ	I-NP	O
pressure	pressure	NN	I-NP	O
sore	sore	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
right	right	JJ	I-NP	O
big	big	JJ	I-NP	O
toe	toe	NN	I-NP	O
was	be	VBD	B-VP	O
tender	tender	NN	B-NP	O
to	to	TO	B-PP	O
palpation	palpation	NN	B-NP	O
.	.	.	O	O

LABORATORY	LABORATORY	NN	B-NP	O
STUDIES	STUDIES	NNS	I-NP	O
:	:	:	O	O
Labs	Lab	NNS	B-NP	B-protein
were	be	VBD	B-VP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
creatinine	creatinine	NN	I-NP	O
of	of	IN	B-PP	O
3.4	3.4	CD	B-NP	O
and	and	CC	O	O
an	an	DT	B-NP	O
INR	INR	NN	I-NP	B-protein
of	of	IN	B-PP	O
7.1	7.1	CD	B-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
EKG	EKG	NN	I-NP	B-protein
showed	show	VBD	B-VP	O
normal	normal	JJ	B-NP	O
sinus	sinus	NN	I-NP	O
rhythm	rhythm	NN	I-NP	O
at	at	IN	B-PP	O
75	75	CD	B-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
BY	BY	NNP	I-NP	O
PROBLEMS	PROBLEMS	NNP	I-NP	O
:	:	:	O	O
Problem	Problem	NNP	B-NP	O
#	#	#	B-NP	O
1	1	CD	I-NP	O
.	.	.	O	O

Infectious	Infectious	JJ	B-NP	O
Disease	Disease	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
vancomycin	vancomycin	NN	B-NP	O
IV	IV	CD	I-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
for	for	IN	B-PP	O
his	his	PRP$	B-NP	O
right	right	JJ	I-NP	O
medial	medial	JJ	I-NP	O
thigh	thigh	JJ	I-NP	O
cellulitis	cellulitis	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
site	site	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
femoropopliteal	femoropopliteal	JJ	I-NP	O
bypass	bypass	NN	I-NP	O
with	with	IN	B-PP	O
rapid	rapid	JJ	B-NP	O
defervescence	defervescence	NN	I-NP	O
and	and	CC	I-NP	O
improvement	improvement	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
drainage	drainage	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
fluctuance	fluctuance	NN	I-NP	O
.	.	.	O	O

Additional	Additional	JJ	B-NP	O
antibiotic	antibiotic	JJ	I-NP	O
coverage	coverage	NN	I-NP	O
was	be	VBD	B-VP	O
added	add	VBN	I-VP	O
specifically	specifically	RB	B-ADVP	O
of	of	IN	B-PP	O
fluoroquinolone	fluoroquinolone	NN	B-NP	O
for	for	IN	B-PP	O
anti-psuedomonal	anti-psuedomonal	JJ	B-NP	O
coverage	coverage	NN	I-NP	O
for	for	IN	B-PP	O
his	his	PRP$	B-NP	O
diabetic	diabetic	JJ	I-NP	O
foot	foot	NN	I-NP	O
ulcers	ulcer	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
right	right	JJ	I-NP	O
heel	heel	NN	I-NP	O
also	also	RB	B-ADVP	O
looked	look	VBD	B-VP	O
increasingly	increasingly	RB	B-ADJP	O
purulent	purulent	JJ	I-ADJP	O
during	during	IN	B-PP	O
his	his	PRP$	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
and	and	CC	I-NP	O
bilateral	bilateral	JJ	I-NP	O
foot	foot	NN	I-NP	O
plain	plain	NN	I-NP	O
films	film	NNS	I-NP	O
were	be	VBD	B-VP	O
done	do	VBN	I-VP	O
.	.	.	O	O

These	These	DT	B-NP	O
were	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
for	for	IN	B-PP	O
osteomyelitis	osteomyelitis	NN	B-NP	O
but	but	CC	O	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
metal	metal	NN	I-NP	O
sliver	sliver	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
foot	foot	NN	I-NP	O
and	and	CC	O	O
an	an	DT	B-NP	O
acute	acute	JJ	I-NP	O
fracture	fracture	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
first	first	JJ	I-NP	O
metatarsal	metatarsal	NN	I-NP	O
.	.	.	O	O

Surgical	Surgical	JJ	B-NP	O
debridement	debridement	NN	I-NP	O
was	be	VBD	B-VP	O
done	do	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
operating	operating	NN	I-NP	O
room	room	NN	I-NP	O
with	with	IN	B-PP	O
drainage	drainage	NN	B-NP	O
of	of	IN	B-PP	O
pus	pus	NN	B-NP	O
,	,	,	O	O
but	but	CC	O	O
the	the	DT	B-NP	O
metal	metal	NN	I-NP	O
showed	show	VBD	B-VP	O
could	could	MD	B-VP	O
not	not	RB	I-VP	O
be	be	VB	I-VP	O
located	locate	VBN	I-VP	O
even	even	RB	B-ADVP	O
with	with	IN	B-PP	O
fluoroscopy	fluoroscopy	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
will	will	MD	B-VP	O
complete	complete	VB	I-VP	O
a	a	DT	B-NP	O
14-day	14-day	JJ	I-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
levofloxacin	levofloxacin	NN	B-NP	O
and	and	CC	I-NP	O
clindamycin	clindamycin	NN	I-NP	O
for	for	IN	B-PP	O
these	these	DT	B-NP	O
foot	foot	NN	I-NP	O
ulcers	ulcer	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
discharged	discharge	VBN	I-VP	O
home	home	NN	B-ADVP	O
with	with	IN	B-PP	O
visiting	visit	VBG	B-VP	O
nursing	nursing	NN	B-NP	O
care	care	NN	I-NP	O
for	for	IN	B-PP	O
b.i.d.	b.i.d.	RB	B-NP	O
wet-to-dry	wet-to-dry	JJ	I-NP	O
dressing	dress	VBG	I-NP	O
changes	change	NNS	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
will	will	MD	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
Jerold	Jerold	NNP	B-NP	O
Cristopher	Cristopher	NNP	I-NP	O
Blazon	Blazon	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
in	in	IN	B-PP	O
one	one	CD	B-NP	O
to	to	TO	I-NP	O
two	two	CD	I-NP	O
weeks	week	NNS	I-NP	O
.	.	.	O	O

Problem	Problem	NNP	B-NP	O
#	#	#	B-NP	O
2	2	CD	I-NP	O
.	.	.	O	O

Renal	Renal	JJ	B-ADJP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
volume	volume	NN	B-NP	O
overloaded	overload	VBN	B-VP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
torsemide	torsemide	NN	I-NP	O
was	be	VBD	B-VP	O
changed	change	VBN	I-VP	O
to	to	TO	B-PP	O
IV	IV	CD	B-NP	O
and	and	CC	O	O
metolazone	metolazone	NN	B-NP	O
was	be	VBD	B-VP	O
added	add	VBN	I-VP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
30	30	CD	B-NP	O
minutes	minute	NNS	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
his	his	PRP$	B-NP	O
first	first	JJ	I-NP	O
torsemide	torsemide	NN	I-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
diuresis	diuresis	NN	I-NP	O
of	of	IN	B-PP	O
1.5-2	1.5-2	CD	B-NP	O
liters	liter	NNS	I-NP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
was	be	VBD	B-VP	O
achieved	achieve	VBN	I-VP	O
with	with	IN	B-PP	O
this	this	DT	B-NP	O
regimen	regimen	NN	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
exception	exception	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
4	4	CD	I-NP	O
liter	liter	NN	I-NP	O
diuresis	diuresis	NN	I-NP	O
overnight	overnight	RB	B-ADVP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
first	first	JJ	I-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
electrolytes	electrolyte	NNS	I-NP	O
were	be	VBD	B-VP	O
replaced	replace	VBN	I-VP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
.	.	.	O	O

I	I	PRP	B-NP	O
have	have	VBP	B-VP	O
expected	expect	VBN	I-VP	O
his	his	PRP$	B-NP	O
creatinine	creatinine	NN	I-NP	O
increase	increase	NN	I-NP	O
to	to	TO	B-PP	O
4.5	4.5	CD	B-NP	O
by	by	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
will	will	MD	B-VP	O
need	need	VB	I-VP	O
close	close	JJ	B-NP	O
renal	renal	JJ	I-NP	O
follow	follow	JJ	I-NP	O
ups	up	NNS	I-NP	O
as	as	IN	B-SBAR	O
he	he	PRP	B-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
approaching	approach	VBG	I-VP	O
need	need	NN	B-NP	O
for	for	IN	B-PP	O
dialysis	dialysis	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
Renal	Renal	NNP	I-NP	O
Service	Service	NNP	I-NP	O
followed	follow	VBD	B-VP	O
him	him	PRP	B-NP	O
during	during	IN	B-PP	O
this	this	DT	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
and	and	CC	B-PP	O
at	at	IN	B-PP	O
their	their	PRP$	B-NP	O
recommendation	recommendation	NN	I-NP	O
,	,	,	O	O
spironolactone	spironolactone	NN	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
discontinued	discontinue	VBN	I-VP	O
upon	upon	IN	B-PP	O
discharge	discharge	NN	B-NP	O
since	since	IN	B-PP	O
his	his	PRP$	B-NP	O
diuresis	diuresis	NN	I-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
slowed	slow	VBN	I-VP	O
.	.	.	O	O

Problem	Problem	NNP	B-NP	O
#	#	#	I-NP	O
3	3	CD	I-NP	O
.	.	.	O	O

Vascular	Vascular	JJ	B-ADJP	O
:	:	:	O	O
Diuresis	Diuresis	NN	B-NP	O
was	be	VBD	B-VP	O
essential	essential	JJ	B-ADJP	O
for	for	IN	B-PP	O
resolution	resolution	NN	B-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
cellulitis	cellulitis	NN	I-NP	O
.	.	.	O	O

Pletal	Pletal	NNP	B-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
and	and	CC	O	O
because	because	IN	B-PP	O
of	of	IN	I-PP	O
his	his	PRP$	B-NP	O
severe	severe	JJ	I-NP	O
peripheral	peripheral	JJ	I-NP	O
arterial	arterial	JJ	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
will	will	MD	B-VP	O
require	require	VB	I-VP	O
excellent	excellent	JJ	B-NP	O
wound	wound	NN	I-NP	O
care	care	NN	I-NP	O
to	to	TO	B-VP	O
optimize	optimize	VB	I-VP	O
healing	healing	NN	B-NP	O
.	.	.	O	O

Problem	Problem	NNP	B-NP	O
#	#	#	B-NP	O
4	4	CD	I-NP	O
.	.	.	O	O

Heme	Heme	NN	B-NP	B-protein
:	:	:	O	O
Initially	Initially	RB	B-ADVP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
Coumadin	Coumadin	NN	I-NP	O
was	be	VBD	B-VP	O
held	hold	VBN	I-VP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
supratherapeutic	supratherapeutic	JJ	I-NP	O
INR	INR	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
was	be	VBD	B-VP	O
restarted	restart	VBN	I-VP	O
when	when	WRB	B-ADVP	O
his	his	PRP$	B-NP	O
INR	INR	NN	I-NP	B-protein
was	be	VBD	B-VP	O
2.2	2.2	CD	B-NP	O
and	and	CC	O	O
he	he	PRP	B-NP	O
his	his	PRP$	B-NP	O
now	now	RB	B-ADVP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
therapeutic	therapeutic	JJ	I-NP	O
range	range	NN	I-NP	O
and	and	CC	O	O
will	will	MD	B-VP	O
need	need	VB	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
.	.	.	O	O

Problem	Problem	NNP	B-NP	O
#	#	#	B-NP	O
5	5	CD	I-NP	O
.	.	.	O	O

Cardiovascular	Cardiovascular	JJ	B-ADJP	O
:	:	:	O	O
He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
hypertensive	hypertensive	JJ	B-ADJP	O
on	on	IN	B-PP	O
arrival	arrival	NN	B-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
Hydralazine	Hydralazine	NN	B-NP	O
initially	initially	RB	B-ADVP	O
and	and	CC	O	O
transitioned	transitione	VBN	B-VP	O
to	to	TO	B-PP	O
his	his	PRP$	B-NP	B-DNA
p.o.	p.o.	FW	I-NP	O
home	home	NN	I-NP	O
medicines	medicine	NNS	I-NP	O
.	.	.	O	O

Even	Even	RB	B-ADVP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
large	large	JJ	I-NP	O
cuff	cuff	NN	I-NP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
run	run	VB	I-VP	O
high	high	JJ	B-ADVP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
150s-180s	150s-180	NNS	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
hospital	hospital	NN	B-NP	O
day	day	NN	I-NP	O
#	#	#	B-NP	O
9	9	CD	I-NP	O
,	,	,	O	O
Hydralazine	Hydralazine	NN	B-NP	O
p.o.	p.o.	NN	I-NP	O
was	be	VBD	B-VP	O
added	add	VBN	I-VP	O
with	with	IN	B-PP	O
good	good	JJ	B-NP	O
effect	effect	NN	I-NP	O
which	which	WDT	B-NP	O
lowered	lower	VBD	B-VP	O
his	his	PRP$	B-NP	O
systolic	systolic	JJ	I-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
range	range	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
120s-130s	120s-130	NNS	I-NP	O
.	.	.	O	O

Goal	Goal	NNP	B-NP	O
is	be	VBZ	B-VP	O
below	below	IN	B-PP	O
130/80	130/80	CD	B-NP	O
.	.	.	O	O

Problem	Problem	NNP	B-NP	O
#	#	#	B-NP	O
6	6	CD	I-NP	O
.	.	.	O	O

Endocrine	Endocrine	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
with	with	IN	B-PP	O
NPH	NPH	NN	B-NP	B-protein
and	and	CC	I-NP	O
Humalog	Humalog	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
Diabetes	Diabetes	NNP	I-NP	O
Service	Service	NNP	I-NP	O
saw	see	VBD	B-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
and	and	CC	B-PP	O
at	at	IN	B-PP	O
their	their	PRP$	B-NP	O
recommendation	recommendation	NN	I-NP	O
NPH	NPH	NN	I-NP	O
doses	dose	NNS	I-NP	O
were	be	VBD	B-VP	O
increased	increase	VBN	I-VP	O
,	,	,	O	O
and	and	CC	O	O
he	he	PRP	B-NP	O
is	be	VBZ	B-VP	O
now	now	RB	B-ADVP	O
on	on	IN	B-PP	O
90	90	CD	B-NP	O
units	unit	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
morning	morning	NN	I-NP	O
and	and	CC	O	O
85	85	CD	B-NP	O
units	unit	NNS	I-NP	O
at	at	IN	B-PP	O
night	night	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
goal	goal	NN	I-NP	O
for	for	IN	B-PP	O
this	this	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
below	below	IN	B-PP	O
150	150	CD	B-NP	O
particularly	particularly	RB	I-NP	O
given	give	VBN	I-VP	O
the	the	DT	B-NP	O
need	need	NN	I-NP	O
for	for	IN	B-PP	O
wound	wound	NN	B-NP	O
healing	healing	NN	I-NP	O
.	.	.	O	O

Problem	Problem	NNP	B-NP	O
#	#	#	I-NP	O
7	7	CD	I-NP	O
:	:	:	O	O
GI	GI	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
seen	see	VBN	I-VP	O
by	by	IN	B-PP	O
Nutrition	Nutrition	NN	B-NP	O
and	and	CC	O	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
evaluated	evaluate	VBN	I-VP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
by	by	IN	B-PP	O
Bariatric	Bariatric	NNP	B-NP	O
Surgery	Surgery	NNP	I-NP	O
pending	pende	VBG	B-PP	O
next	next	JJ	B-NP	O
week	week	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
of	of	IN	B-PP	O
utmost	utmost	JJ	B-NP	O
importance	importance	NN	I-NP	O
for	for	IN	B-PP	O
this	this	DT	B-NP	O
patient	patient	NN	I-NP	O
with	with	IN	B-PP	O
life-threatening	life-threatening	JJ	B-NP	O
morbid	morbid	JJ	I-NP	O
obesity	obesity	NN	I-NP	O
who	who	WP	B-NP	O
already	already	RB	B-ADVP	O
has	have	VBZ	B-VP	O
severe	severe	JJ	B-NP	O
complications	complication	NNS	I-NP	O
of	of	IN	B-PP	O
obesity-related	obesity-related	JJ	B-NP	O
conditions	condition	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
obesity	obesity	NN	B-NP	O
,	,	,	O	O
hyperventilation	hyperventilation	NN	B-NP	O
syndrome	syndrome	NN	I-NP	O
.	.	.	O	O

Problem	Problem	NNP	B-NP	O
#	#	#	B-NP	O
8	8	CD	I-NP	O
.	.	.	O	O

Pulmonary	Pulmonary	JJ	B-ADJP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
obstructive	obstructive	JJ	B-NP	O
sleep	sleep	NN	I-NP	O
apnea	apnea	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
CPAP	CPAP	NN	I-NP	B-DNA
machine	machine	NN	I-NP	I-DNA
was	be	VBD	B-VP	O
brought	bring	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
bedside	bedside	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
unable	unable	JJ	B-ADJP	O
to	to	TO	B-VP	O
tolerate	tolerate	VB	I-VP	O
the	the	DT	B-NP	O
nose	nose	NN	I-NP	O
mask	mask	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
will	will	MD	B-VP	O
use	use	VB	I-VP	O
his	his	PRP$	B-NP	O
own	own	JJ	I-NP	O
device	device	NN	I-NP	O
when	when	WRB	B-ADVP	O
he	he	PRP	B-NP	O
returns	return	VBZ	B-VP	O
home	home	NN	B-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
INSTRUCTIONS	INSTRUCTIONS	NNS	I-NP	O
:	:	:	O	O
He	He	PRP	B-NP	O
will	will	MD	B-VP	O
go	go	VB	I-VP	O
home	home	NN	B-ADVP	O
with	with	IN	B-PP	O
visiting	visit	VBG	B-VP	O
nurse	nurse	NN	B-NP	O
care	care	NN	I-NP	O
and	and	CC	O	O
will	will	MD	B-VP	O
need	need	VB	I-VP	O
to	to	TO	I-VP	O
see	see	VB	I-VP	O
his	his	PRP$	B-NP	O
nephrologist	nephrologist	NN	I-NP	O
,	,	,	O	O
vascular	vascular	JJ	B-NP	O
surgeons	surgeon	NNS	I-NP	O
,	,	,	O	O
primary	primary	JJ	B-NP	O
care	care	NN	I-NP	O
provider	provider	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
Bariatric	Bariatric	NNP	B-NP	O
Surgery	Surgery	NNP	I-NP	O
following	follow	VBG	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

eScription	eScription	NN	B-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
3-5081947	3-5081947	CD	B-NP	O
EMSSten	EMSSten	NNP	I-NP	O
Tel	Tel	NNP	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
GREIBER	GREIBER	NNP	B-NP	O
,	,	,	O	O
JORDON	JORDON	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
BARTOSIK	BARTOSIK	NNP	B-NP	O
,	,	,	O	O
RICK	RICK	NNP	B-NP	O
ARMAND	ARMAND	NNP	I-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
3091355	3091355	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
8/7/03	8/7/03	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
8/7/03	8/7/03	CD	B-NP	O

